Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS)

Clinical trial NCT00903760 · COMPLETED

Trial details

NCT number: NCT00903760
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome

Start date: 2010-01-01
Primary completion: 2015-06-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.